Benjamin Brady

Dr Benjamin Brady is a highly skilled medical oncologist specialising in the field of haematology and medical oncology, with a particular focus on breast cancer. He currently serves as the Director of Haematology and Medical Oncology at Cabrini Malvern, located in the suburb of Malvern in Melbourne, Victoria, Australia.

Dr Brady obtained his Bachelor of Science with Honours degree before completing his Bachelor of Medicine and Bachelor of Surgery (BMBS) at Flinders University in South Australia in 1990. He subsequently received his Fellowship of the Royal Australasian College of Physicians (FRACP) qualification, demonstrating his advanced expertise in the field.

With over two decades of experience in oncology, Dr Brady brings a wealth of knowledge and skill to his practice. Prior to his tenure at Cabrini Health, he completed additional medical oncology studies in the United States, further enhancing his expertise in the field.

Dr Brady's primary interest lies in the treatment of breast cancer, and he has developed a considerable practice in this area. Committed to providing the highest standard of care, he ensures that his patients receive individualized treatment plans tailored to their specific needs. Dr Brady also actively participates in clinical research trials at Cabrini, contributing to advancements in cancer treatment and care.

In addition to his role at Cabrini Malvern, Dr Brady holds an appointment at the esteemed Peter MacCallum Cancer Institute, further highlighting his dedication and contribution to the field of oncology.

Whilst Dr Brady's professional focus and expertise lies within oncology, his other interests beyond the medical realm are currently not specified.

In summary, Dr Benjamin Brady is a respected and accomplished medical oncologist, specialising in haematology and medical oncology, with a particular focus on breast cancer. With a career spanning over two decades, he has established himself as a trusted practitioner, providing compassionate care and contributing to advancements in cancer treatment and research.